Page 116 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine 18 F-FDG PET & unexplained inflammatory syndromes

Funding 4. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron
emission tomographic imaging in the detection and
None. monitoring of infection and inflammation. Semin Nucl Med.
2002;32(1):47-59.
Conflict of interest
doi: 10.1053/snuc.2002.29278
The authors declare that they have no competing interests.
5. Dumarey N, Egrise D, Blocklet D, et al. Imaging infection
Author contributions with 18F-FDG-labeled leukocyte PET/CT: Initial experience
in 21 patients. J Nucl Med. 2006;47(4):625-632.
Conceptualization: Salah Oueriagli Nabih, Meryem 6. Rini JN, Palestro CJ. Imaging of infection and inflammation
Aboussabr, Ikram Zahfir, with 18F-FDG-labeled leukocytes. Q J Nucl Med Mol
Formal analysis: Salah Oueriagli Nabih, Meryem Imaging. 2006;50(2):143-146.
Aboussabr.
Investigation: Omar Ait Sahel, Yassir Benameur 7. Park IN, Ryu JS, Shim TS. Evaluation of therapeutic
Methodology: Salah Oueriagli Nabih response of tuberculoma using F-18 FDG positron emission
Writing – original draft: Salah Oueriagli Nabih tomography. Clin Nucl Med. 2008;33(1):1-3.
Writing – review & editing: Salah Oueriagli Nabih, doi: 10.1097/RLU.0b013e31815c5128
Abderrahim Doudouh 8. Bleeker-Rovers CP, Vos FJ, Corstens FH, Oyen WJ. Imaging
of infectious diseases using [18F] fluorodeoxyglucose PET.
Ethics approval and consent to participate Q J Nucl Med Mol Imaging. 2008;52(1):17-29.
All procedures performed in studies involving human 9. Bleeker-Rovers CP, Vos FJ, Wanten GJ, et al. 18F-FDG
participants were in accordance with the ethical standards PET in detecting metastatic infectious disease. J Nucl Med.
of the Institutional and/or National Research Committee 2005;46(12):2014-2019.
and with the 1964 Helsinki Declaration and its later 10. Jamar F, Buscombe J, Chiti A, et al. EANM/SNMMI
amendments or comparable ethical standards. For this guideline for 18F-FDG use in inflammation and infection.
interesting image, formal consent is not required. J Nucl Med. 2013;54(4):647-658.
Consent for publication doi: 10.2967/jnumed.112.112524

Written informed consent was obtained from all patients 11. Salomäki SP, Saraste A, Kemppainen J, et al. 18F-FDG
for publication. positron emission tomography/computed tomography in
infective endocarditis. J Nucl Cardiol. 2017;24(1):195-206.
Availability of data doi: 10.1007/s12350-015-0325-y
Authors make available to all scientists, documents 12. Bleeker-Rovers CP, De Kleijn EM, Corstens FH, Van der
described in the manuscript, including new software, Meer JW, Oyen WJ. Clinical value of FDG PET in patients
databases, and all relevant raw data. with fever of unknown origin and patients suspected of focal
infection or inflammation. Eur J Nucl Med Mol Imaging.
References 2004;31(1):29-37.
1. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, doi: 10.1007/s00259-003-1338-3
Ido T. Intratumoral distribution of fluorine-18- 13. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET
fluorodeoxyglucose in vivo: High accumulation in and PET/CT in fever of unknown origin. J Nucl Med.
macrophages and granulation tissues studied by 2007;48(1):35-45.
microautoradiography. J Nucl Med. 1992;33(11):1972-80.
14. Blockmans D, Knockaert D, Maes A, et al. Clinical value of
2. Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake [(18)F]fluoro-deoxyglucose positron emission tomography
and glucose transporter subtype expressions in for patients with fever of unknown origin. Clin Infect Dis.
experimental tumor and inflammation models. J Nucl Med. 2001;32(2):191-196.
2001;42(10):1551-1555.
doi: 10.1086/318480
3. Prabhakar HB, Rabinowitz CB, Gibbons FK, O’Donnell WJ,
Shepard JA, Aquino SL. Imaging features of sarcoidosis 15. Hao R, Yuan L, Kan Y, Li C, Yang J. Diagnostic performance of
on MDCT, FDG PET, and PET/CT. AJR Am J Roentgenol. 18F-FDG PET/CT in patients with fever of unknown origin:
2008;190(3 Suppl):S1-S6. A meta-analysis. Nucl Med Commun. 2013;34(7):682-688.
doi: 10.2214/AJR.07.7001 doi: 10.1097/MNM.0b013e328361cd0e

Volume 3 Issue 1 (2025) 108 doi: 10.36922/arnm.5895